| 000 | 00930 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250515222520.0 | ||
| 264 | 0 | _c20120508 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1573-0646 | ||
| 024 | 7 |
_a10.1007/s10637-010-9434-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavidson, Terence M | |
| 245 | 0 | 0 |
_aA short report on article by V. Pruliere-Escabasse et al., vol. 27: 285-286, 2009. _h[electronic resource] |
| 260 |
_bInvestigational new drugs _cFeb 2012 |
||
| 300 |
_a423; author reply 424 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aEpistaxis _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRhinitis _xchemically induced |
| 773 | 0 |
_tInvestigational new drugs _gvol. 30 _gno. 1 _gp. 423; author reply 424 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10637-010-9434-2 _zAvailable from publisher's website |
| 999 |
_c19796803 _d19796803 |
||